Delivery Order SPE2DB24D8001-SPE2DB24FKYXA
Award Date
8/13/24
Potential Completion Date
8/14/24
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,595.91, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc. The contract is a firm fixed-price delivery order for the pharmaceutical product ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBPWS, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, with a ceiling value of $3,267.50. The contract has an ultimate completion date of October 16, 2023 and was awarded on October 13, 2023. This award is not associated with a set-aside program,...
This is a federal contract award by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,953.97 Firm Fixed Price delivery order contract is for the provision of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product. The contract has an ultimate completion date of October 25, 2023 and is not associated with a set-aside program. Dakota Drug, Inc. holds a significant single-award...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $6,286.96 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products. This award is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows the company to deliver a comprehensive range of medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML medical supplies. The contract has a ceiling value of $10,699.02 and a period of performance through April 28, 2023. This delivery order contract is part of Dakota Drug, Inc.'s larger indefinite delivery contract (IDC) with the DLA Troop Support Medical division, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,489.36, is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a wide range of pharmaceutical...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBQCG, was made by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, with a ceiling value of $7,645.48 and a completion date of December 1, 2023. Dakota Drug, Inc. is a critical supplier of pharmaceutical products, medical supplies, and healthcare...
This is a firm-fixed-price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The contract is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, with a ceiling value of $6,881.93 and a period of performance through June 24, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to federal agencies, particularly the U.S. Armed Forces. This delivery order...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $4,904.78, is for the delivery of Actemra Actpen 162 mg/0.9 ml, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract is a Firm Fixed Price Delivery Order with a performance period ending on May 22, 2024. Dakota Drug, Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, identified as SPE2DB24D8001 and SPE2DB25FKZLV, is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products. The contract has a firm fixed price, with a ceiling value of $7,858.70, and an ultimate completion date of April 2, 2025. Dakota Drug, Inc. is the prime contractor and there is no set-aside designation for this...